Alpha-Lipoic Acid
Alpha-Lipoic Acid (ALA) is a potent antioxidant with evidence for improving insulin sensitivity and reducing symptoms of diabetic neuropathy. It functions as both a water- and fat-soluble antioxidant, giving it unique versatility in combating oxidative stress throughout the body.
Quick Verdict
Solid evidence for diabetic neuropathy and modest blood sugar benefits, but less compelling for healthy individuals.
Best suited for those with type 2 diabetes, metabolic syndrome, or diabetic neuropathy. Healthy individuals may benefit from its antioxidant properties but the effects will be less noticeable.
At a Glance
Dose
300-600mg/day
When to Take
On an empty stomach for best absorption
Best Form
R-alpha lipoic acid
Evidence
57% avg
What It Is
Alpha-Lipoic Acid is a naturally occurring organosulfur compound synthesized in small amounts by the human body. It functions as a cofactor for mitochondrial enzymes involved in energy metabolism, particularly pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. Unlike most antioxidants, ALA is both water- and fat-soluble, allowing it to work in virtually every tissue and cell compartment. It also regenerates other antioxidants including vitamins C and E, glutathione, and coenzyme Q10. Supplemental ALA is available as a racemic mixture (R/S-ALA) or as the more bioactive R-lipoic acid form.
How It Works
ALA exerts its effects through multiple mechanisms. As an antioxidant, it directly scavenges reactive oxygen species and chelates transition metals that catalyze free radical production. It enhances glucose uptake by activating AMPK (AMP-activated protein kinase) and promoting GLUT4 translocation to cell membranes, improving insulin sensitivity. In neuropathy, ALA improves nerve blood flow, reduces oxidative stress in neural tissue, and enhances nerve conduction velocity. It also upregulates endogenous antioxidant defenses by activating the Nrf2 transcription factor pathway, boosting production of glutathione and other protective enzymes.
Evidence by Goal
neuropathy
Good evidence from multiple RCTs that intravenous and oral ALA reduces symptoms of diabetic peripheral neuropathy including pain, burning, and numbness.
blood sugar
Moderate evidence supports ALA improving insulin sensitivity and reducing fasting glucose, particularly in individuals with type 2 diabetes or metabolic syndrome.
Dosage & Usage
Standard Dose
300-600mg/day
Loading Protocol
No loading phase required; effects develop over 3-5 weeks of consistent use
Timing
On an empty stomach for best absorption; 30 minutes before meals
Best Form
R-alpha lipoic acid (more bioactive) or racemic ALA
📅 What to Expect
Week 1-2
Antioxidant capacity increasing. Blood sugar effects may appear within days.
Week 4-8
Neuropathy symptoms (tingling, numbness) may begin improving in diabetics.
Week 8-12
Full neuropathy benefit in responders. Fasting glucose modestly lower.
Month 3+
Sustained nerve protection. Weight loss effects (if any) are minimal.
🎯 How to Know It's Working
Blood sugar more stable after meals
Less nerve tingling if diabetic neuropathy
Antioxidant markers improve on bloodwork
If not working: If no blood sugar improvement after 8 weeks at 600mg/day, may not be your primary issue. More effective in diabetic populations.
🏷️ Buying Guide
✓ Look For
- • R-lipoic acid (bioactive form)
- • 300-600mg per serving
- • Stabilized R-ALA (Na-RALA)
✗ Avoid
- • Racemic ALA without specifying R-form
- • Mega-doses above 1200mg without supervision
🥗 Get It From Food
🛡️ Safety Profile
Common Side Effects
- • nausea on empty stomach
- • skin rash (rare)
- • mild GI discomfort
⚠️ Contraindications
- 🚫 thiamine deficiency (ALA may worsen symptoms)
💊 Drug Interactions
- • insulin and oral hypoglycemics (may enhance blood sugar lowering)
- • thyroid medications (may lower T3/T4 levels)
🔴 Serious Risks
- • hypoglycemia when combined with diabetes medications
Long-Term Safety
Well-tolerated in studies lasting up to 4 years at doses of 600mg/day. No serious adverse effects observed in controlled trials. Widely used in clinical practice in Europe for diabetic neuropathy.
👥 Who Benefits Most
Best For
- ✓ individuals with type 2 diabetes
- ✓ those with diabetic peripheral neuropathy
- ✓ people with metabolic syndrome
- ✓ individuals seeking antioxidant support
Less Effective For
- — healthy young adults with normal glucose metabolism
- — those seeking acute effects
📚 Key Research
3 peer-reviewed studies supporting this supplement's effects.
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis (ALADIN III)
Ziegler D, Ametov A, Barinov A, et al. · Diabetes Care (2006)
ALA at 600mg/day IV for 3 weeks significantly reduced neuropathic symptoms including pain, burning, and paresthesia in diabetic patients compared to placebo.
N-Acetylcysteine — a safe antidote for cysteine/glutathione deficiency
Atkuri KR, Mantovani JJ, Herzenberg LA, et al. · Current Opinion in Pharmacology (2007)
Review establishing the role of thiol antioxidants including ALA in restoring glutathione levels and protecting against oxidative damage in clinical conditions with glutathione depletion.
Alpha-lipoic acid as a biological antioxidant
Shay KP, Moreau RF, Smith EJ, et al. · Biochimica et Biophysica Acta (2009)
Comprehensive review establishing ALA as a unique antioxidant capable of regenerating other antioxidants and activating endogenous antioxidant defense systems through Nrf2 signaling.
💰 Cost & Forms
Estimated Monthly Cost
$15-35
🔗 Related Evidence Reviews
Want a personalized stack?
Our Stack Builder recommends supplements based on your goals, conditions, and lifestyle.
✨ Build My Stack